Skip to main content

fda_approval · nda · info

ABBVIE INC — NDA approval: JUVMO (unspecified)

Event date
2026-09-25 00:00:00Z
Observed
2026-10-03 04:30:44Z
Source ID
NDA220415-1
Payload hash
fea7c79d6aee9fb77c239ba6…

Summary

ABBVIE INC received NDA approval for JUVMO (unspecified) on 2026-09-25. Dosage form: TABLET. Application #: NDA220415.

Entities

Frequently asked questions

Has AbbVie Inc. had other FDA enforcement actions?
Yes. Argus HQ has recorded 5 total FDA actions tied to AbbVie Inc.: 0 warning letters, 4 recalls, 1 approval record, and 0 Form 483 inspection citations.
What kind of FDA record is this?
This is an Argus HQ record of a FDA Drug Approval, tagged info severity by Argus HQ. FDA published the underlying record on 2026-09-25; Argus observed and indexed it on 2026-10-03.
Where can I verify this record directly with FDA?
The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA
Argus HQ Research (2026). ABBVIE INC — NDA approval: JUVMO (unspecified). Digital Empire Holdings LLC. Retrieved from https://argushq.ai/events/fda-approval-abbvie-inc-nda220415-1
MLA
"ABBVIE INC — NDA approval: JUVMO (unspecified)." Argus HQ Research, Digital Empire Holdings LLC, 2026, argushq.ai/events/fda-approval-abbvie-inc-nda220415-1.
Chicago
Argus HQ Research. "ABBVIE INC — NDA approval: JUVMO (unspecified)." Digital Empire Holdings LLC. Accessed October 3, 2026. https://argushq.ai/events/fda-approval-abbvie-inc-nda220415-1.
BibTeX
@misc{argushq_argushq_ai_events_fda_approval_abbvie_inc_nda220415_1_2026,
  title = {ABBVIE INC — NDA approval: JUVMO (unspecified)},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/events/fda-approval-abbvie-inc-nda220415-1},
  note = {Accessed: October 3, 2026}
}

Informational only. Not legal, financial, or medical advice.